ARTICLE | Clinical News
Microsponge formulation of 5-fluorouracil regulatory update
November 6, 2000 8:00 AM UTC
The FDA granted marketing approval for the company's Microsponge formulation of 5-FU to treat actinic keratoses. Dermik Laboratories Inc., a subsidiary of Aventis S.A. (AVE, Strasbourg, France), will...